The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407

FEMS Microbiology Letters

Volumn 310, Issue 1, 2010, Pages 17-23

  Murzyn, Anna ^a   Krasowska, Anna ^a   Augustyniak, Daria ^a   Majkowska Skrobek, Grazyna ^a   Łukaszewicz, Marcin ^a,b   Dziadkowiec, Dorota ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

adhesion; Caco 2; Candida albicans; cytokines; Intestin 407; Saccharomyces boulardii

Indexed keywords

BUTYRIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA;

ARTICLE; CANDIDA ALBICANS; CELL ADHESION; CELL CULTURE; CELL STRAIN CACO 2; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES BOULARDII;

CANDIDA ALBICANS; CELL ADHESION; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; PROBIOTICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES;

CANDIDA ALBICANS; SACCHAROMYCES BOULARDII;

EID: 77955255550     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02037.x     Document Type: Article

References (32)

1. Apte RN Voronov E (2002) Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol 12 : 277 290.
2. Berg R, Bernasconi P, Fowler D Gautreaux M (1993) Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J Infect Dis 168 : 1314 1318.
3. Bleichner G, Bléhaut H, Mentec H Moyse D (1997) Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intens Care Med 23 : 517 523.
4. Buts J de Keyser N (2006) Effect of Saccharomyces boulardii on intestinal mucosa. Digest Dis Sci 51 : 1485 1492.
5. Czerucka D, Dahan S, Mograbi B, Rossi B Rampal P (2000) Saccharomyces boulardii preserve the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68 : 5998 6004.
6. Egusa H, Nikawa H, Makihira S, Yatani H Hamada T (2006) In vitro mechanisms of interleukin-8-mediated responses of human gingival epithelial cells to Candida albicans infection. Int J Med Microbiol 296 : 301 311.
7. Freshney RI (2002) Culture of epithelial cells. Isolation and Culture of Intestinal Epithelial Cells, Chapter 10, 2nd edn (Booth C O'Shrea A, eds), pp. 330 331. Wiley-Liss, New York.
8. Gillum AM, Tsay EY Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198 : 179 182.
9. Jawhara S Poulain D (2007) Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol 45 : 691 700.
10. Kagnoff MF Eckmann L (1997) Epithelial cells as sensors for microbial infection. J Clin Invest 100 : 6 10.
11. Kimura LH Pearsall NN (1978) Adherence of Candida albicans to human buccal epithelial cells. Infect Immun 21 : 64 68.
12. Kojic EM Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17 : 255 267.
13. Krasowska A, Murzyn A, Dyjankiewicz A, Łukaszewicz M Dziadkowiec D (2009) The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res 9 : 1312 1321.
14. Lammers KM, Helwig U, Swennen E, Rizzello F, Venturi A, Caramelli E, Kamm MA, Brigidi P, Gionchetti P Campieri M (2002) Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 97 : 1182 1186.
15. Lee SK, Kim YW, Chi SG, Joo YS Kim HJ (2008) The effect of Saccharomyces boulardii on human colon cells and inflammation in rats with trinitrobenzene sulfonic acid-induced colitis. Digest Dis Sci 54 : 255 263.
16. Lo H-J, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A Fink GR (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90 : 939 949.
17. Marcil A, Harcus D, Thomas DY Whiteway M (2002) Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment. Infect Immun 70 : 6319 6329.
18. McFarland LV, Surawicz CM, Greenberg RN et al 1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotic for Clostridium difficile disease. JAMA-J Am Med Assoc 271 : 1913 1918.
19. Mukherjee PK Chandra J (2004) Candida biofilm resistance. Drug Resist Update 7 : 301 309.
20. National Committee for Clinical Laboratory Standards (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast Approved Standard M27-A2, 2nd edn. National Committee for Clinical Laboratory Standards, Wayne, PA.
21. Noverr MC Huffnagle GB (2004) Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun 72 : 6206 6210.
22. Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, Lamont JT Kelly CP (2001) Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridum difficile toxin A in mice. Infect Immun 69 : 2762 2765.
23. Saegusa S, Totsuka M, Kaminogawa S Hosoi T (2004) Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol Med Mic 41 : 227 235.
24. Saegusa S, Totsuka M, Kaminogawa S Hosoi T (2007) Cytokine responses of intestinal epithelial-like Caco-2 cells to non-pathogenic and opportunistic pathogenic yeasts in the presence of butyric acid. Biosci Biotech Bioch 71 : 2428 2434.
25. Saint-Marc T, Rossello-Prats L Touraine JL (1991) Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Ann Med Interne 142 : 64 65.
26. Saville SP, Lazzell AL, Monteagudo C Lopez-Ribot JL (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2 : 1053 1060.
27. Sougioultzis S, Simeonidis S, Ramakrishnan Bhaskar K, Chen X, Anton PM, Keates S, Pothoulakis C Kelly CP (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expression. Biochem Bioph Res Co 343 : 69 76.
28. Southern P, Horbul J, Maher D Davis DA (2008) C. albicans colonization of human mucosal surfaces. PLoS One 3 : e2067.
29. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J van Belle G (1989) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96 : 981 988.
30. Swidsinski A, Loening-Baucke V, Verstraelen H, Osowska S Doerffel Y (2008) Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology 135 : 568 579.
31. Villar CC, Kashleva H Dongari-Bagtzoglou A (2004) Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol Immun 19 : 262 269.
32. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF Achong MK (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101 : 311 320.